16 March 2012

Pronota Strengthens Management Team
Former VP Corporate Development Genzyme joins as CBO.More

15 March 2012

Shire to acquire FerroKin BioSciences, Inc., and its Phase
2 iron chelator treatment.More

20 January 2012

Pronota announces EUR 3.7 million Series C financing ; management and board changes.More

30 December 2011

Syndexa Pharmaceuticals Expands Series B1 Financing Round with investment by MP Healthcare Venture Management, Inc. More

31 October 2011

GenKyoTex Starts Phase 1 Trial with First in Class NOX inhibitor GKT137831. Dual NOX1/4 Inhibitor Targets Treatment of Diabetic Nephropathy. More